Re-Recontextualising Novo Nordisk - Not so Cheap Anymore
When I wrote my piece on Novo Nordisk yesterday, I was not expecting their Annual Report to be released the same day along with a 2026 guidance...
297 Views
Recontextualizing Novo Nordisk in the Current Obesity Race
Since my previous write up on Novo Nordisk, the business has had a few good news and the stock is up 18%. Yet it remains ~3x cheaper than it’s...
162 Views